Strong promoters are the key to highly efficient, noninflammatory and noncytotoxic adenoviral-mediated transgene delivery into the brain in vivo

Molecular Therapy

Volumn 2, Issue 4, 2000, Pages 330-338

  Gerdes, Christian A ^a   Castro, Maria G ^a   Löwenstein, Pedro R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

BETA GALACTOSIDASE; CD8 ANTIGEN;

ADENOVIRUS; ANIMAL; ARTICLE; BIOSYNTHESIS; BRAIN; CELL CULTURE; CELL STRAIN COS1; CHO CELL; CORPUS STRIATUM; CYTOMEGALOVIRUS; CYTOTOXICITY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; GENETICS; HAMSTER; HELA CELL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METABOLISM; METHODOLOGY; PHYSIOLOGY; PLASMID; PROMOTER REGION; RAT; SPRAGUE DAWLEY RAT; TRANSGENE;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD8; BETA-GALACTOSIDASE; BRAIN; CHO CELLS; CORPUS STRIATUM; COS CELLS; CRICETINAE; CYTOMEGALOVIRUS; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PLASMIDS; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; TRANSGENES; TUMOR CELLS, CULTURED;

EID: 0034294843     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0140     Document Type: Article

References (27)

1. Anderson, W. F. (1998). Human gene therapy. Nature 392: 25-30.
2. Blomer, U., Naldini, L., Kafri, T., Trono, D., Verma, V., and Gage, F. H. (1997). Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71: 6641-6649.
3. Dewey, R. A., et al. (1999). Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials. Nat. Med. 5: 1256-1263.
4. Thomas, C. E., Birkett, D., Castro M. G., and Lowenstein, P. R. (2000). The role of vector toxicity versus inflammatory and immune responses in eliminating adenovirus vector-mediated transgene expression from the rat brain. Submitted.
5. Wood, M. J., Charlton, H. M., Wood, K. J., Kajiwara, K., and Byrnes, A. P. (1996). Immune responses to adenovirus vectors in the nervous system. Trends Neurosci. 19: 497-501.
6. Addison, C. L., Hitt, M., Kunsen, D., and Graham, F. L. (1997). Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors. J. Gen. Virol. 78: 1653-1661.
7. Sallanave, J. M., Xing, Z., Simpson, A. J., Graham, F. L., and Gauldie, J. (1998). Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): A comparison of different promoters. Gene Ther. 5: 352-360.
8. Marr, R. A., Hitt, M., Muller, W. J., Gauldie, J., and Graham, F. L. (1998). Tumour therapy in mice using adenovirus vectors expressing human TNFα. Int. J. Oncol. 12: 509-515.
9. Morelli, A. E., et al. (1999). Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Gen. Virol. 80: 571-583.
10. Southgate, T. D., Kingston, P. A., and Castro, M. G. (2000). In Current Protocols in Neurosdence (J. N. Crawley, C. R. Gerfen, R. McKay, M. A. Rogawski, D. R. Sibley, and P. Skolnick, Eds.). Wiley, New York.
11. Southgate, T., et al. (2000). Transcriptional targeting to anterior pituitary lactotrophic cells using recombinant adenovirus vectors in vitro and in vivo. Endocrinology, 141: 3493-3505.
12. Byrnes, A. P., Wood, M. J. A., and Charlton, H. M. (1996). Role of T cells in inflammation caused by adenovirus vectors in the brain. Gene Ther. 3: 644-651.
13. Wilkinson, G. W., and Akrigg, A. (1992). Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res. 20: 2233-2239.
14. Shering, A. F., et al. (1997). Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors. J. Gen. Virol. 78: 445-459.
15. Nyberg-Hoffman, C., Shabram, P., Li, W., Giroux, D., and Aguilar-Cordova, E. (1999). Sensitivity and reproducibility in adenoviral infectious titer determination. Nat. Med. 3: 808-811.
16. Dion, D. L., Fang, J., and Carver, R. I., Jr. (1996). Supernatant rescue assay vs polymerase chain reaction for detection of wild type adenovirus-contaminating recombinant adenovirus stocks. J. Virol. Methods 56: 99-107.
17. Cotten, M., Baker, A., Saltik, M., Wagner, E., and Buschle, M. (1994). Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus. Gene Ther. 1: 239-246.
18. Thomas, C. E., Abordo-Adesida, E., Maleniak, T. C., Stone, D., Gerdes, C. A., and Lowenstein, P. R. (2000). In Current Protocols in Neuroscience (J. N. Crawley, C. R. Gerfen, R. McKay, M. A. Rogawski, D. R. Sibley, and P. Skolnick, Eds.). Wiley, New York.
19. Abercrombie, M. (1946). Estimation of nuclear populations from microtome sections. Anat. Rec. 94: 239-247.
20. Mittereder, N., March, K. L., and Trapnell, B. C. (1996). Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70: 7498-7509.
21. Luria, S. E., Darnell, J. E., Jr., Baltimore, D., and Campbell, A. (Eds.) (1978). In General Virology, pp. 21-32. Wiley, New York.
22. Bobo, R. H., Laske, D. W., Akbasak, A., Morrison, P. F., Dedrick, R. L., and Oldfield, E. H. (1994). Convection-enhanced delivery of macromolecules in the brain. Proc. Natl. Acad. Sci. USA 91: 2076-2080.
23. Smith-Arica, J., Morelli, A. E., Larregina, A. T., Smith, J., Lowenstein, P. R., and Castro, M. (2000). Cell-type-specific and regulatable transgenesis in the adult brain: Adenovirus-encoded combined transcriptional targeting and indu cible transgene expression. Submitted.
24. Cartmell, T., Southgate, T., Rees, G. S., Castro, M. G., Lowenstein, P. R., and Luheshi, G. N. (1999). Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain. J. Neurosci. 19: 1517-1523.
25. Thomas, C. E., Schiedner, G., Kochanek, S., Castro, M. G., and Lowenstein, P. R. (2000). Peripheral infection with adenovirus causes unexpected long term brain inflammation in animals injected intracranially with first generation, but not with high capacity adenovirus vectors: Toward realistic long term neurological gene therapy for chronic diseases. Proc Natl. Acad. Sci. USA 97: 7482-7487.
26. Roelvnik, P. W., Mi Lee, G., Einfeld, D. A., Kovesdi, I., and Wickham, T. J. (1999). Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 286: 1568-1571.
27. Douglas, J. T., et al. (1999). A system for the propagation of adenoviral vectors with genetically modified receptor specificities. Nat. Biotech. 17: 470-475.